Joel Greenblatt's ABUS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 0 shares of Arbutus Biopharma Corporation (ABUS) worth $0, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in ABUS, representing a fresh investment thesis on this company. Largest reduction occurred in Q2 2026, reducing 17,321 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Arbutus Biopharma Corporation (ABUS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arbutus Biopharma Corporation (ABUS) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -17,321 | Sold Out | 0 | $0.00 |
| Q1 2026 | +17,321 | New Buy | 17,321 | $4.50 |
Joel Greenblatt's Arbutus Biopharma Corporation Investment FAQs
Joel Greenblatt first purchased Arbutus Biopharma Corporation (ABUS) in Q1 2026, acquiring 17,321 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Arbutus Biopharma Corporation (ABUS) for 2 quarters since Q1 2026.
Joel Greenblatt's largest addition to Arbutus Biopharma Corporation (ABUS) was in Q1 2026, adding 17,321 shares worth $77,945.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 0 shares of Arbutus Biopharma Corporation (ABUS), valued at approximately $0.
As of the Q2 2026 filing, Arbutus Biopharma Corporation (ABUS) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Arbutus Biopharma Corporation (ABUS) was 17,321 shares, as reported at the end of Q1 2026.